Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/1024
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection
Zhang, B
Liu, S
Tan, T
Huang, W
Dong, Y
Chen, L
Chen, Q
Zhang, L
Zhong, Q
Zhang, X
Zou, Y
Zhang, S
Acceso Abierto
Atribución-NoComercial-SinDerivadas
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally and the number is still increasing rapidly. Herein, we presented four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all the four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy.
Chest (American College of Chest Physicians)
2020
Preimpreso
https://coronavirus.1science.com/item/c7ac698760db28705e645a68f7214f1776cfc8c1
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
104691.pdf294 kBAdobe PDFView/Open